← Compounds

N-Acetyl Selank Amidate

peptide · headlineResearch use only

Modulates GABAergic neurotransmission via gene expression and receptor sensitivity

Summary

N-Acetyl Selank Amidate is a nootropic peptide derived from tuftsin and enhanced through N-acetylation for improved stability. It modulates GABA, serotonin, and neurotrophic signaling and has demonstrated powerful anti-anxiety, cognitive-enhancing, and immunomodulatory effects in preclinical and clinical settings. Its intranasal use enables fast CNS action with a high safety margin. It has been investigated in Russian research for immune modulation and neurochemical balance.

How it works

  • Modulates GABAergic neurotransmission via gene expression and receptor sensitivity
  • Influences serotonin and dopamine balance through neuropeptide regulation
  • Upregulates BDNF expression and neuroplasticity markers
  • Reduces pro-inflammatory cytokines in brain and periphery
  • Enhances adaptive stress response and immune homeostasis

Dosing

  • unit: mcg
    low dose: 200
    frequency: 1–3x daily
    high dose: 500
    standard dose: 300
    administration route: Intranasal

Cycling

  • Use 1–3x per day for 10–14 days. Repeat cycles monthly as needed for mood, anxiety, or performance support.

Side effects

long term: ["Limited long-term human data on N-Acetyl Selank specifically; safety extrapolated from Selank clinical use"]

Chemistry & PK

sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
half life: Likely short (5–15 minutes in plasma); longer CNS effects due to gene expression changes
degradation: Cleared by tissue peptidases
molecular weight: 751.89
molecular formula: C33H57N11O9
tissue specificity: CNS regions regulating anxiety, stress, and learning (amygdala, hippocampus, cortex)

Verified citations

3 · PubMed-checked
  • Functional Connectomic Approach to Studying Selank and Semax Effects.clinicalPMID 32342318
  • Selank Attenuates Aversive Signs of Morphine Withdrawal in Rats.preclinicalPMID 36322304
  • Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety.preclinicalPMID 28280289

Legal / compounding

Research use only

Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.